Tumor-derived GM-CSF drives the accumulation of regulatory T-cells (Tregs) in the TME through generation of monocyte-derived DCs, and GM-CSF may therefore be a therapeutic target alongside radiotherapy [28]. Here, CSF2 is linked to neoplasm.